Genetic aspects of gynaecological diseases: new approaches to diagnosis and treatment
DOI:
https://doi.org/10.56294/saludcyt20251195Keywords:
Genetic aspects, Gynaecological diseases, Diagnosis, TreatmentAbstract
Currently, there is no consensus among experts regarding the causes of gynaecological diseases. It is hypothesized that various environmentales factors, such as an unhealthy lifestyle (smoking, overeating, and lack of physical activity), may influence the development of gynaecological diseases. Therefore, the aim of the work will be to investigate the genetic aspects of gynecological diseases, from diagnostic methods to treatment. However, the hypothesis of genetic origin is considered particularly important in the etiopathogenesis of gynecological diseases. The main strategies for identifying and treating women's health ailments with a genetic component have been examined. Although numerous studies have been conducted, the regulation of the reproductive system and the pathogenesis of hormone-dependent pathologies are still not fully understood. These problems are complex and relevant in both the scientific sphere and practical medicine. In gynecological practice, the most frequent conditions among women of reproductive age are fibroids, adenomyosis, and ovarian cysts. These conditions often require radical surgery. Recently, there has been a trend of younger patients experiencing disruptions in their reproductive function, often resulting in infertility ranging from 30-80 %. The clinical presentation of the disease is severe, with prolonged and heavy bleeding, complications, and progressive pain. This can lead to a loss of work capacity and psychoemotional disorders. Therefore, this issue is extremely relevant. At the time of examination, the duration of the disease ranged from 1 to 10 years. Patients reported complaints of heavy or prolonged menstruation, menstrual cycle disturbances, lower abdominal pain, and infertility. The clinical picture and patients' complaints indicate a genetic association with the disease.
References
Ajao MO, Oliveira Brito LG, Wang KC. Persistence of symptoms after total vs supracervical hysterectomy in women with histopathological diagnosis of adenomyosis. J. of Minimally Invasive Ginecoligy. 2019;26(2):891-896. https://doi.org/10.1016/j.jmig.2018.09.002
Aleksandrovych V, Basta P, Gil K. Current facts constituting an understanding of the nature of adenomyosis. Adv. Clin. Exp. Med. 201;28(6):839-846. https://doi.org/10.17219/acem/79176
Soeda S, Hirajawa T, Takata M, Kamo N, Sekino H, Nomura, S. Unique learning system for uterine artery embolization for symptomatic myoma and adenomyosis for obstetrician and gynecologists in cooperation with interventional radiologists: evaluation of UAE from the point of view of gynecologists who perform UAE. J. of Minimally Invasive Gynecology. 2018;25(1): 84-92. https://doi.org/10.1016/j.jmig.2017.08.008
Yoon JK, Han K, Kim MD, Kim GM, Kwon JH. Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: an analysis of risk factors for reintervention. European J. of Radiology. 2018;119: 83-87. https://doi.org/10.1016/j.ejrad.2018.10.017
Gracia M, Nonell R, Ros C, Rius M, Quintas L. Sonographic and hysteroscopic endometrial examination in women treated with ulipristal acetate: Exploratory findings at a tertiary referral center. European J. of Obstetrics and Gynecology and Reproductive Biology. 2019;232:40-45. https://doi.org/10.1016/j.ejogrb.2018.11.009
Tamhane N, McDowell M, Oliva M, Tanner JP, Hochberg L. Association between preoperative adenomyosis detection rate during pelvic ultrasonography and the specialty of the reading physician. J. of Minimally Invasive Gynecology. 2019;27(2):504-509. https://doi.org/10.1016/j.jmig.2019.04.015
Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895-2015. Nat. Rev. Cancer. 2015;15:181-194. https://doi.org/10.1038/nrc3878
Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int. J. Androl. 2006;29(1):278-285. PMID: 16390494. https://doi.org/10.1111/j.1365-2605.2005.00623.x
Naamneh ER, du Toit T, Flück CE. Basics of androgen synthesis and action. Best. Pract. Res. Clin. Endocrinol. Metab. 2022;36:101665. https://doi.org/10.1016/j.beem.2022.101665
Lewy VD, Danadian K, Witchel SF, Arslanian S. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J. Pediatr. 2001;138:38-44. https://doi.org/10.1067/mpd.2001.109603
Caglayan A, Katlan DC, Tuncer ZS, Yuce K, Sayal HB. Assessment of oxidant-antyoxidant status alterations with tumor biomarkers and reproductive system hormones in uterine myomas. European J. of Obstetrics and Gynecology and Reproductive Biology. 2018; 229:1-7. https://doi.org/10.1016/j.ejogrb.2018.07.031
Azziz R.: Polycystic Ovary Syndrome. Obstet. Gynecol. 2018;132(2):321-336. https://doi.org/10.1097/AOG.0000000000002698
Costello MF, Misso ML, Balen A, Boyle J, Devoto L, Garad RM, et al. A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome. Aust. N. Z. J. Obstet. Gynaecol. 2019;59(6):867-873. https://doi.org/10.1111/ajo.13051
Cunha A, Póvoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed. J. 2021;6(1):116. https://doi.org/10.1097/j.pbj.0000000000000116
Jain T, Negris O, Brown D, Galic I, Salimgaraev R, Zhaunova L. Characterization of polycystic ovary syndrome among Flo app users around the world. Reprod. Biol. Endocrinol. 2021;19(1):36. https://doi.org/10.1186/s12958-021-00719-y
Allen LA, Shrikrishnapalasuriyar N, Rees DA. Long-term health outcomes in young women with polycystic ovary syndrome: A narrative review. Clin. Endocrinol. (Oxf.). 2022;97(2):187-198. https://doi.org/10.1111/cen.14609
Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 2018; 14:270-284. https://doi.org/10.1038/nrendo.2018.24
Hu KL, Chen Z, Li X, Cai E, Yang H, Chen Y. Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reprod. Biol. Endocrinol. 2022;20(1):81. https://doi.org/10.1186/s12958-022-00953-y
Teede HJ, Tay CT, Laven JE, Dokras A, Moran LJ, Piltonen TT. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur. J. Endocrinol. 2023;189(2):43-64. https://doi.org/10.1093/ejendo/lvad096
Castro J, Rosca AS, Cools P, Vaneechoutte M, Cerca N. Gardnerella vaginalis enhances Atopobium vaginae viability in a vitro model. Front. Cell. Infect. Microbiol. 2020; 10:83. https://doi.org/10.3389/fcimb.2020.00083
Liptáková A, Čurová K, Záhumenský J, Visnyaiová K, Varga I. Microbiota of female genital tract – functional overview of microbial flora from vagina to uterine tubes and placenta. Physiol. Res. 2022;71(1):21-33. https://doi.org/10.33549/physiolres.934960
Muzny CA, Taylor CM, Swords WE. An updated conceptual model on the pathogenesis of bacterial vaginosis. J. Infect. Dis. 2019;220(9):1399-1405. https://doi.org/10.1093/infdis/jiz342
Winkler HA, Tomeszko JE, Sand PK. Anterior sacrospinous vaginal vault suspension for prolapse. Obstet. Gynecol. 2000;95(4):612-615. https://doi.org/10.1016/S0029-7844(99)00615-8
Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int. Braz. J. Urol. 2020;46(1):5-14. https://doi.org/10.1590/S1677-5538.IBJU.2018.058
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Nataliia Veresniuk, Liudmyla Polishchuk, Olena Buhaiova, Tetiana Fartushok (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
